SCOPUS 정보 검색 플랫폼

Volumn 4, Issue 9, 1995, Pages 853-859

Section review: Pulmonary-allergy, dermatological, gastrointestinal & arthritis: Newer immunosuppressive drugs and other agents for the treatment of rheumatoid arthritis - An update

(1) Carlson, Richard P a

a PFIZER INC (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (3 DIMETHYLAMINOPROPYL) 8,8 DIPROPYL 2 AZASPIRO[4.5]DECANE; [10 METHOXY 4H BENZO[4,5]CYCLOHEPTA[1,2 B]THIOPHEN 4 YLIDENE]ACETIC ACID; ANTIRHEUMATIC AGENT; ATIPRIMOD; CYCLOSPORIN A; CYCLOSPORIN A [8 DEXTRO O (2 HYDROXYETHYL)SERINE]; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; NEW DRUG; RAPAMYCIN; TACROLIMUS; TENIDAP; TERIFLUNOMIDE; UNCLASSIFIED DRUG;

ANIMAL MODEL; CLINICAL TRIAL; DRUG FORMULATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

EID: 0029147943 PISSN: 13543784 EISSN: None Source Type: Journal
DOI: 10.1517/13543784.4.9.853 Document Type: Article

Times cited : (8)

References (39)

1
- 85081480309
- Etiology and pathogenesis of rheumatoidarthritis. In: Arthritis and Allied Conditions. McCarty DJ, Koopman WJ (Eds.). Lea and Febiger, Philadelphia-London. A good chapter on the aetiology and pathogenesis of rheumatoid arthritis.
- (1993)
- ZVAIFLER, N.J.¹

2
- 0025817428
- MHC class II molecules andautoitnmunity
- :–.
- (1991) Ann. Rev. Immunol. , vol.9 , pp. 493-525
- NEPOM, G.T.¹ EHRLICH, H.²

3
- 0027464778
- Rheumatoid arthritis: How well do the theories fit the evidence? din.Exp. Immunol.. A good brief review on the aetiopathogenesis of rheumatoid arthritis.
- (1993) , vol.92 , pp. 1-6
- MCCULLOCH, j.¹ LYDYARD, P.M.² ROOK, G.A.W.³

4
- 0027463331
- Pathogenesis of rheumatoid arthritis
- :–.
- (1993) lancet , vol.341 , Issue.8840 , pp. 283-286
- SE WELL, K.L.¹ TRENTHAM, D.E.²

5
- 84966070436
- Newer immunosuppressive drugs and other agents for the treatment of rheumatoid arthritis
- :–.
- (1993) Curr. Opin. Invest. Drugs , vol.2 , Issue.7 , pp. 751-762
- CARLSON, R.P.¹

6
- 0027960223
- TUGWELL P: The use of cyclosporin A in rheumatoid arthritis
- :–.
- (1994) Br. J. Rheumatol. , vol.33 , Issue.10 , pp. 967-969
- PANAY', G.S.¹

7
- 85081483562
- Rapamycin (Si-rolimus, Rapamune): A novel immunosuppressive agent. Kimball E (Ed.). CRC Press. In press.
- MOLNAR-KIMBER, K.L.¹ SEHGAL, S.N.²

8
- 85081476079
- Effects of different oral formulations of sirolienus (Rapamycin, Rapamune6) and combination therapy with cyclosporin A in the rat developing adju-vant arthritis model
- (1994) Abstract from the Seventh Interna-tional Conference of the Inflammation Research Association , pp. 106
- HARTMAN, D.A.¹ OCHALSKI, S.J.² ZIMMERMAN, J.L.³ SEHGAL, S.N.⁴ CARLSON, R.P.⁵

9
- 0016713286
- Rapamycin (AY-22,989), a new antifungal antibiotic H
- :–.
- (1975) Fermentation, isolation and characterization. J. Antibiot. , vol.28 , Issue.10 , pp. 727-732
- SEHGAL, S.N.¹ BAKER, H.² VEZINA, C.³

10
- 0028069835
- MOLNAR-KIMBER KL: A putative sirolimus (rapamycin) effector protein
- :–.
- (1994) Biochem. Biophys. Res. Commun. , vol.203 , pp. 1-7
- CHEN, Y.¹ CHEN, H.² RHOADS, A.E.³ WARNER, L.⁴ CAGGIANO, T.J.⁵ FAILLI, A.H.Z.⁶ HSIANO, C.L.⁷ NAKANISHI, K.⁸

11
- 85081490714
- MOLNAR-KIMBER KL: Isolation of a sirolimus (rapamycin) effector protein
- (1994) Abstractfrom Seventh International Conference of the Inflam-mation Research Association , pp. W53
- CHEN, Y.¹ CHEN, H.² RHOAD, A.³ WARNER, L.M.⁴ CAGGIANO, T.⁵ FAILLI, A.⁶ ZHANG, H.⁷ NAKANISHI, K.⁸

12
- 0028360374
- SCHREIBER SL: A mammalian protein targeted by G-1 arresting rapamycin receptor complex
- :–.
- (1994) Nature , vol.369 , Issue.6483 , pp. 756-758
- BROWN, E.J.¹ ALBERS, M.W.² SHIN, T.B.³ ICHIKAWA K, K.⁴ LANE, W.S.⁵

13
- 0028239893
- A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORS
- :–.
- (1994) Cell , vol.78 , Issue.1 , pp. 35-43
- SABATINI, D.M.¹ ERDJUMENT-BROMAGE, H.² LUIM, T.³ SNYDER, S.R.⁴

14
- 0028598672
- RAFT1, a mammalian homolog of yeast TOR, interacts with the FKBP12/ra-pamycin complex
- :–.
- (1994) Proc. Natl. Acad. Sci. USA , vol.92 , Issue.25 , pp. 12574-12578
- CHIU, M.I.¹ KATZ, H.² BERLIN, V.³

15
- 0027280944
- Effect of a short course of rapamycin, cyclosporin A, and donor-specific transfu-sion on rat cardiac allograft survival
- :–.
- (1993) Transplantation , vol.55 , Issue.5 , pp. 1107-1112
- DAVIES, C.B.¹ MADDEN, R.L.² ALEXANDER, J.W.³ COFER, B.R.⁴ FISHER, R.A.⁵ ANDERSON, P.⁶

16
- 0027268303
- Immunosuppressive effects of rapamycin in experi-mental organ allografting
- :–,
- (1993) Transplantation , vol.56 , Issue.1 , pp. 15-19
- OCHIAI, T.¹ GUNJI, Y.² NAGATA, M.³ ASANO, T.⁴ ISONO, K.⁵

17
- 0027958718
- Quantitative and temporal analysis of the cellular inter-action of FK-506 and rapamycin in T-lymphocytes
- :–.
- (1994) J. Pharmacol. Exp. Then , vol.268 , Issue.1 , pp. 32-41
- DUMONT, F.j.¹ KASTNER, C.² IACOVONE, F.³ FISCHER, P.A.⁴

18
- 85081479737
- 1932 :
- (1993) Scrip , pp. 23

19
- 85081480732
- 1970 :
- (1994) Scrip , pp. 23

20
- 85081482712
- ).
- (1994) Pharrnaprojects (May

21
- 0028353685
- The effects of tenidap on cytokine induced proliferation of human synovial fibroblasts in vitro
- :–.
- (1994) Annals Rheum. Dis. , vol.53 , Issue.4 , pp. 250-255
- MATTEY, D.L.¹ EVANS, E.² DAWES, P.T.³

22
- 85081484183
- Tenidap effectively reduces cytokine syn-thesis and expression by human rheumatoid arthritis synovium. Arth. Rheum. 37(Suppl.):.
- (1994) , pp. S309
- MARTEL-PELLETIER, J.¹ OUNISSI, H.² CLOUTIER, J.M.³ POUTER, J.P.⁴

23
- 0028169743
- Effects of tenidap on Ca2 -and protein kinase C-mediated protein phosphoryla-don activation of arachidonate-mobilizing phospholi-pase A2 and subsequent eicosanoid formation in macrophages
- :–.
- (1994) Btochem. Pharmacol. , vol.48 , Issue.6 , pp. 1171-1179
- BONDESON, j.¹ SUNDLER, R.²

24
- 85081486141
- (The Pink Sheet) (August, ):.
- (1992) FDC Reports , pp. 10

25
- 85081484839
- ).
- (1994) Pharmaprojects (December

26
- 85081488397
- ).
- (1995) Pharmaprojects (February

27
- 85081480908
- IX –. Br. J. Rheumatol. :75–78.
- (1991) Phar-macologic effects of a new antiarrhythmic agent , vol.30 , pp. 207-887
- MACKENZIE, A.R.¹ BOLLINGER, P.² COOPER, P.H.³ DEL POZO, E.⁴ ELFORD, P.⁵ GRAEBER, M.⁶ BUGLER, H.U.⁷ LEUTWILER, A.⁸ PAYNE, T.⁹ RUCH, W.¹⁰ SCHNYDER, J.¹¹ WUETHRICH, H.-J.¹²

28
- 0026806988
- IX 207-887 in rheuma-toid arthritis
- :–.
- (1992) Arth. Rheum. , vol.35 , Issue.9 , pp. 999-1006
- DOUGADOS, N.¹ COMBE, B.² BEVERIDGE, T.³ BOURDEIX, I.⁴ LALLEMAND, A.⁵ AMOR, B.⁶ SANY, J.⁷

29
- 0028324255
- Measurement of inter-leukin-1 liberation in zymosan air-pouch exudate in mice. Agents Actions :–.
- (1994) , vol.41 , Issue.1/2 , pp. 93-95
- ERDO, F.¹ TOROK, K.² SZEICELY, J.L.³

30
- 0028985102
- J. Pharmacol. Exp. Ther. :–. It represents good experimental evidence in detail for the mechanism of action of leflunomide.
- (1995) The in2munosuppressant leflunomideInhibits lymphocyte progression through cell cycle by a novel mechanism , vol.272 , Issue.1 , pp. 460-468
- CHERWINSKI, H.M.¹ MCCARLEY, D.² SCHATZMAN, R.³ DEVENS, B.⁴ RANSOM, J.T.⁵

31
- 85081483765
- a reversible inhibitor of pyrimidine biosyn-thesis? Abstract from the Seventh International Conference of the Inflammation Research Association :.
- (1994) Le-flunomide , pp. P105
- ZIELINSKI, T.¹ ZEITTER, D.² MeLLNER, S.³ BARTLETT, R.R.⁴

32
- 0027937148
- Agents Actions 41(Special Conference Issue):–.
- (1994) The influence of leflunomide on cell cycle IL-2 receptor (IL-2R) and its gene expression , pp. C204-205
- ZIELINSKI, T.¹ HERMANN, M.² MULLER, H.-J.³ REIDEL, N.⁴ BAR-TLETT, R.R.⁵

33
- 85081486697
- Suppression of autokrunune responses and Inflammatory events by leflunomide in an animal model for rheumatoid arthritis. Agents Actions 41(Special Conference Issue):.
- (1994)
- GIANT, T.T.¹ MIICECZ, K.² BRENNAN, F.³ NEGRIOU, G.⁴ BAR-TLETT, R.R.⁵

34
- 85081480246
- Agents Actions 41(Special Conference Issue):.
- (1994) Inhibition of interleukin 2 (IL-2)-stimu-lated tyrosine kinase activity by leflunomide
- NIKCEVICH, D.A.¹ FINNEGAN, A.² CHONG, A.S-F.³ WILLIAMS, J.W.⁴ BREMER, E.G.⁵

35
- 85081478785
- ).
- (1995) Pharmaprojects (April

36
- 0028889906
- Separation of immunomodulatory and cholesterol lowering activi-ties of heterocyclic azaspiranes
- :–.
- (1995) J. Pharm. Exp. Tber. , vol.272 , Issue.1 , pp. 689-698
- ALBRIGHTSON, C.R.¹ BUGELSKI, P.J.² BERKHOUT, T.A.³ JACK-SON, B.⁴ KERNS, W.D.⁵ ORGAN, A.J.⁶ BADGER, A.M.⁷

37
- 0025114093
- Antiarthritic and suppressor cell induc-ing activity of azaspiranes: structure-function relation-ships of a novel class of immunomodulatory agents
- :–.
- (1990) J Med. Cbem. , vol.33 , Issue.11 , pp. 2963-2970
- BADGER, A.M.¹ SCHWARTZ, D.A.² PICKER, D.H.³ DORMAN, J.W.⁴ BRADLEY, P.C.⁵ CHEESEMAN, E.N.⁶ DIMARTINO, M.J.⁷ HANNA, N.⁸ MIRABELLI, C.K.⁹

38
- 85081478183
- Azaspiranes with therapeutic activity in animal models of autoimmune disease and organ transplantation. New immunosup-pressive modalities in organ transplantation. Kupiec-Weglinski JW (Ed.). RG Landes Company.
- (1994)
- BADGER, A.M.¹ KUPIEC-WEGLINSKI, J.W.²

39
- 85081487855
- Suppressor cell (SC) activity induced by the azaspiranes may reside in a non-adherent or semiadherent tissue macrophage population. J. Immunol. (8 ):75A. Richard P Carlson, Wyeth-Ayerst Research, CN 8000, Princeton, NJ –, USA.
- (1993) , vol.150 , pp. 8000-08543
- BADGER, A.M.¹ SWIFT, B.A.² BUGELSKI, P.J.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.